ATUM
Integrated biologics development partner offering in‑house gene design and synthesis, machine‑learning driven sequence optimization, protein expression and purification across bacterial, yeast and mammalian hosts, protein engineering and cell line development. Services and platforms are offered from sequence design through research cell bank creation, with laboratory operations in the San Francisco Bay Area.
Industries
Nr. of Employees
medium (51-250)
Patents
Services
Design and synthesis of codon‑optimized genes for expression in mammalian, bacterial and yeast hosts; sequence optimization to improve expression and other functional properties.
End‑to‑end protein production from small‑scale screening to multi‑liter cultures with purification and formulation services for antibodies, antigens and enzymes.
Parallel screening of hundreds to thousands of candidates for expression yield and developability metrics, delivering screening quantities suitable for binding and developability assays.
Stable cell line generation and transient CHO‑based discovery workflows designed to facilitate transition from discovery to manufacturing, with licensing options for cell line platforms.
Customized analytical packages including HPLC, mass spectrometry, BLI kinetics, endotoxin testing and biophysical assays to support lead selection and regulatory studies.
Design and synthesis of codon‑optimized genes for expression in mammalian, bacterial and yeast hosts; sequence optimization to improve expression and other functional properties.
End‑to‑end protein production from small‑scale screening to multi‑liter cultures with purification and formulation services for antibodies, antigens and enzymes.
Parallel screening of hundreds to thousands of candidates for expression yield and developability metrics, delivering screening quantities suitable for binding and developability assays.
Stable cell line generation and transient CHO‑based discovery workflows designed to facilitate transition from discovery to manufacturing, with licensing options for cell line platforms.
Customized analytical packages including HPLC, mass spectrometry, BLI kinetics, endotoxin testing and biophysical assays to support lead selection and regulatory studies.
Expertise Areas
- Biologics development (sequence to research cell bank)
- Gene design and codon optimization
- Protein expression and purification
- Cell line development for mammalian biologics
Key Technologies
- Machine‑learning driven sequence design
- Codon optimization
- Transient and stable CHO expression
- High‑throughput HEK expression screening
News & Updates
Industry event listing for participation in Bioplus Interphex, Seoul, Korea (Oct 28-30, 2026).
Event listing for PEGS EU, Lisbon, Portugal (Nov 17-19, 2026).
Coverage referencing genome editing applications for biopharmaceutical manufacturing.
Article referencing local research efforts; hosted link on site to external coverage.
Awarded a gene synthesis grant from NIH/NHGRI (mentioned on site news listings).
Awarded a DARPA bioengineering grant (listed in site news items).
Industry event listing for participation in Bioplus Interphex, Seoul, Korea (Oct 28-30, 2026).
Event listing for PEGS EU, Lisbon, Portugal (Nov 17-19, 2026).
Coverage referencing genome editing applications for biopharmaceutical manufacturing.
Article referencing local research efforts; hosted link on site to external coverage.
Awarded a gene synthesis grant from NIH/NHGRI (mentioned on site news listings).
Awarded a DARPA bioengineering grant (listed in site news items).